Target intelligence / Profile preview

Sinonasal mucosa

Molecular classification
Other (anatomical tissue; composed of respiratory epithelium, not a single molecular family)
01

Overview

The sinonasal mucosa is the thin, moist lining of the nasal cavity and paranasal sinuses. Composed mostly of pseudostratified ciliated columnar epithelium and goblet cells, it functions to condition inhaled air by humidifying, warming, and filtering it. The mucosa produces mucus that traps particulate matter and pathogens, facilitating their removal via mucociliary clearance. It hosts immune cells (macrophages, lymphocytes) and participates in defense against respiratory infections. Diseases affecting the sinonasal mucosa include rhinitis, sinusitis, and sinonasal tumors; treatments often target inflammation or infection within this tissue[1][3][5]. If clarification or a molecular target within the sinonasal mucosa is needed (e.g., "EGFR in sinonasal carcinoma"), please specify, as "sinonasal mucosa" by itself does not meet standard molecular target conventions[2][4].

Other names
Nasal mucosaParanasal sinus mucosaRespiratory mucosa of the sinuses
02

Mechanism of action

Corticosteroids reduce inflammation by inhibiting pro-inflammatory cytokine production in mucosal cells. Decongestants vasoconstrict blood vessels in mucosa, reducing swelling. Antihistamines block histamine receptors, preventing allergy mediator action in mucosa. Saline provides physical cleansing and humidification.

03

Biological functions

Humidification of inhaled airFiltration and trapping of particles/pathogens (via mucus)Immunological defense (contains immune cells)Mucociliary clearance
04

Disease associations

Inflammation (rhinitis, sinusitis)Infection (viral, bacterial, fungal sinusitis)Cancer (site of primary tumors, e.g., sinonasal carcinomas[2][4])Allergic response (allergic rhinitis)
05

Safety considerations

Local irritation (from topical drugs)Mucosal atrophy with chronic steroid useRebound congestion (with prolonged decongestant use)Increased risk of infection with impaired mucosal defense
06

Interacting drugs

Topical corticosteroids (e.g., fluticasone, mometasone)

3 more in the full profile.

Beyond the preview

Go deeper on Sinonasal mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinonasal mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call